GigaMune

0 followers


GigaMune was founded as a spin-out from GigaGen in 2017. They are combining unique insight into T cell responses to tumors with massively parallel T cell receptor (TCR) discovery to develop the next generation of T cell therapies.

Industries

Stage

Employees

Links

Org chart

David Johnson
Founder and CEO

David Johnson

Collapse
Adam Adler
Co-Founder
Carter Keller
Co-Founder
Mark Cobbold
Scientific Co-Founder
Jennifer Keller
Head of Marketing